ATLAS / Macro Radar / Reporting / VRAX

Virax Biolabs Group Ltd (VRAX) reporting calendar

Virax Biolabs Group Ltd files periodic reports with the SEC as VRAX on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.

Latest report
20-F
Period ended
31 Mar 2026
Filed
6 Jul 2026
Reports on record
5
Open VRAX market profile Latest filing on SEC EDGAR ↗ All Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
20-F31 Mar 20266 Jul 202697 days0001193125-26-295158
20-F31 Mar 20252 Jul 202593 days0000950170-25-093260
20-F31 Mar 202420 Aug 2024142 days0000950170-24-099115
20-F31 Mar 202314 Jun 202375 days0000950170-23-027973
20-F31 Mar 202212 Aug 2022134 days0000950170-22-017130

Source: SEC EDGAR company submissions for CIK 0001885827. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.